Detalhe da pesquisa
1.
Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.
Br J Haematol
; 153(5): 599-611, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21492126
2.
Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.
AAPS J
; 17(1): 35-43, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25380723
3.
Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers.
Clin Pharmacol
; 7: 11-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25653564
4.
Conference report: hot topics in antibody-drug conjugate development.
Bioanalysis
; 5(24): 2989-93, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24320125
5.
American Association of Pharmaceutical Scientists National Biotechnology Conference Short Course: Translational Challenges in Developing Antibody-Drug Conjugates: May 24, 2012, San Diego, CA.
MAbs
; 5(1): 5-12, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23255090
6.
Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modeling.
Leuk Res
; 36(11): 1410-6, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22884950